chondroitin sulfate

Contentus

• Potest enim effective ...
• Effectiveness rate ut quod est insufficiens ...
• & Cautiones admonitio specialis;

Quod plerumque in cartilaginem Chondroitin sulfate mixta est inter membra corporis. Chondroitin sulfate plerumque est fabricari, et ex fontibus animalis sicut vacca pristis et cartilagine conectitur. Potest etiam esse in a Lab.

Quidam products sunt intitulatum verius chondroitin sulfate. In quibusdam casibus, moles ad magis quam C% of chondroitin est varius non in quantum est scriptor uber titulus. Item, quod sit quaedam chondroitin products continent multa ex diversis animalibus, etsi hoc non semper dicitur de pittacio adornata sunt.

OSTEOARTHRITIS est chondroitin sulfate adhiberi et inflationibus. Non est saepius utendum cum aliis ingredients, inter Ascorbate manganese, hyaluronic acidum, collagen peptides, et glucosamine. Chondroitin sulfate et sublatus est per os, ut applicari in cute, et multis aliis conditionibus data est a offa in sed est scientific indicio suscipere huiusmodi boni non est usus.

Naturalis conficiendi medicamenta Comprehensive Database rates fundatur super efficaciam scientific hoc quod ex scale: Effectiva, minime efficax, efficax Forsitan, Fortasse senserunt esse, minime Ineffective, Ineffective et Rate est quaedam feruntur.

Et efficaciam ratings chondroitin sulfate ita se habet:

Potest enim effective ...

• catarractas. Research ostendit quod injecting sodium et chondroitin sulfate solutio hyaluronate qui habet oculum ad oculum protegit cataracta durante surgery. Chondroitin sulfate sodium et multa alia products quibus ab Apostolica Sede recognitis hyaluronate Americae Cibus et medicamentis Administration (FDA) suffusio ad usum durante surgery. Tamen suus 'non addit nisi manifestum est chondroitin sulfate sodium hyaluronate solutions succurro reducere pressura intra oculus cataracta post surgery similes aliis treatments comparari. Quidam specifica ad oculum diluculo studiis suadeant quod continet solution et hyaluronate chondroitin sulfate (Viscoat, Alconis habes Laboratories) potest minui et amplio altiore pressura in oculus, oculi sani aquarum multarum, postquam remotum est. Autem, in guttas, non videntur esse meliora quam guttae hyaluronate soli quibus vel alium vocavit chemical hydroxypropylmethyl, Cellulose. In quibus effectus de modo solutions ad cataracta chondroitin sulfate surgery non sciatur.
• Osteogenesis imperfecta. Orci research ostendit quod si accipiatur chondroitin sulfate per os loquens modeste improves dolor OSTEOARTHRITIS est quod aliqui sunt in munus et propter usque ad VI mensibus. Videtur operari optime apud populum gravior dolor est et cum a pharmaceutical praeparatio-gradu usus est. Ostensum est enim quod bonum est in aegris specifica products includit Chondrosulf ex OSTEOARTHRITIS (IBSA Institut Spermatophyta SA), Chondrosan (Bioibérica, S.A.), et Structrum (Pierre Fabre Laboratoires). Sed dolor est verisimile ad esse optimum parva. Alius research ostendit quod si accipiatur usque chondroitin sulfate pro II annos progressum slow ne OSTEOARTHRITIS.
  Quidam research est aestimandam effectis chondroitin sulfate quo capta est per os tandem coniunctim afficient vniuersa glucosaminum. Quidam research ostendit quod continet products accipiens specifica chondroitin et glucosamine sulfate adjuvat reducere signa OSTEOARTHRITIS. Alius research ostendit quod nullum beneficium non-commercial usum scripta sunt. Tollens glucosamine chondroitin sulfate plus videtur slow longus-terminus progressum OSTEOARTHRITIS.
  Est hoc aliquid quod sit cutis crepito chondroitin sulfate quibus tandem coniunctim afficient vniuersa sulfate et glucosamine, turpis cartilaginem versae, cypri OSTEOARTHRITIS potest, redigendum symptoms. Sed quis est signum subsidio verisimile maxime caphura non ex ceteris. Chondroitin investigationis ostendit quod non est absorbetur per cute.
  

Effectiveness rate ut quod est insufficiens ...

• Iuncturam dolor mauris aromatase inhibitors dicitur (aromatase Matrix effecerunt arthralgias). Mane taking investigationis insinuat quod est compositum ex duabus vel tribus divisa doses sulfate in chondroitin et glucosamine sulfate XXIV hebdomades improves cotidie ad iuncturam dolor symptoms causatur ab pharmaca, et facies ad pectus cancer.
• oculum sicco. Investigationis ostendit quod mane chondroitin sulfate per oculum guttae diminui possit siccis oculis. Alius research ostendit quod uti guttae oculis chondroitin sulfate continet, et potes amplio Prunus tum de siccis oculis lacrimae usura artificialis. Et primo investigationes ostendit nullum aliud bonum.
• Fecit per exercitium musculus soreness. Investigationis ostendit quod mane acceptis redigendum musculus soreness post exercitium, non chondroitin sulfate cotidie apud homines.
• Poma (inflammatio) de ventrem (GASTRITIS). Investigationis ostendit quod mane bibere liquido continentur certis ac chondroitin sulfate hyaluronic acidum minuatur musculus dolor potest in populus cum GASTRITIS.
• Vesicae dolorem syndrome (interstitialibus CYSTITIS). Quidam research ostendit liquido posito, quod potest amplio in chondroitin sulfate in vesica urinaria dolorem docebo. Sed qualitas illa studia deorsum. Quidam altioribus studiis suadeant ut uti chondroitin sulfate, qualis intus in vesica, non prodest. Quidam research ostendit quod mane chondroitin sulfate accipere uber et aliis rebus quibus potest amplio per os vesicae dolorem inferens. Patet ex beneficio tamen suus chondroitin sulfate vel ceteris.
• A inordinatio, quod facit ad ossa et artus, plerumque in defectu hominum cum Selenium (Kashin-Beck morbo). Mane investigationis insinuat quod chondroitin sulfate, cum vel sine glucosaminum dose, dolore potest, redigendum est in populo Kashin-Beck morbo. Quoque, taking chondroitin et glucosamine sulfate sulfate potest slow iuncturam spatium intestino angustia in populo huic os morbus. Autem, si incertum est iuncturam spatium concludantur angustiis inlaqueatus est solum taking chondroitin sulfate.
• Cor impetum. Quidam research ostendit quod mane acceptis ex ore demittere periculo chondroitin sulfate prima recurrente habens cor impetum.
• Squamea convolvens, SCABIOSUS cutis (PSORIASIS). 2-3 mensibus primis investigationis insinuat quod si accipiatur chondroitin sulfate melius cute conditionibus et defectum dolor per populus cum PSORIASIS. Sed alia investigationis insinuat quod captivitatis chondroitin sulfate (Condrosan, CS-Bio Active, Bioiberica S.A., Barcelona) cotidie ad III menses genu, et non est minuere PSORIASIS enim primorem populum severissima OSTEOARTHRITIS.
• Damnum imperium ex vesica (urinariorum incontinentia). Mane investigationis insinuat quod interserens CATHETER sodium chondroitin sulfate in vesica urinaria per improves qualis est apud homines in overactive vesicae.
• Infectiones renibus, vesicae, vel urinae (urinariorum tractu infectiones aut UTIs). Investigationis ostendit quod mane administranda chondroitin sulfate solutio continet acidum et hyaluronic in vesica per CATHETER reduces UTIs in numero feminarum UTIs cum historia.
• cutis senescentis.
• obstinatum pectus aestuat.
• Morbus cordis.
• princeps cholesterol.
• Sustuleris fragilis et infirma ossa (Osteoporosis).
• asperae pelles et.
• aliis conditionibus.

Quod magis necesse est ut ad illos usus rate chondroitin sulfate.

In OSTEOARTHRITIS in cartilaginem versae sunt in articulis erumpit. Chondroitin sulfate tollens de aedificium cuneos cartilaginem retardo poterat hic iacet.

Cum sublatus ab oris: Quod chondroitin sulfate CREDIBILIS ARMARIUM. Chondroitin sulfate capta est per os absque timore ullo ad usque annos VI. Potest facere aliquam dolor ac mollis nauseam ventris. Hinc tradita esse effectus bloating ventris constipationem capitis tumidis palpebrae cruribus tumor damnum cutis temerarium, irregulares pulsatio.

Posita in oculo: Quod chondroitin sulfate CREDIBILIS ARMARIUM Cum usus ad oculum solution cataracta durante surgery.

Et datum est iecit: Quod chondroitin sulfate POTEST FIERI ARMARIUM Cum infusum est iecit in musculus, brevis-term.

Salutem cura quaedam animalia ex eo fonte chondroitin sulfate. Quidam sunt anxius quod populus satis tutum, ad vestibulum exercitia ut ne contagione chondroitin infirmabantur animalis products sunt disposita, ut eis, quae transmittunt bubulus spongiform encephalopathy (bos morbus ad insaniam convertunt). Ita quantum sunt non tradit chondroitin ex causa morbo in hominibus, et periculum esse putavit esse humilis.

Quidam products continent nimia amounts of chondroitin manganese. Quaeritur de vestris curis professionales reliable coniciunt.

& Cautiones admonitio specialis;

Graviditate ac loricam pascens: Est cognoscere nisi certa notitia non satis tutum est ut chondroitin sulfate, cum gravida et pectus-pascens. Tuto manere, ne usu.

suspiriosis: Est aliquid de illo facere ut chondroitin sulfate ASTHMA et peius. Si enim brevem temperate uti chondroitin sulfate.

Sanguis perturbationes continens concretionis, In doctrina, in administrando chondroitin sulfate ut crescat periculo sanguinem clotting sanguinis in populum et perturbationes.

prostatae cancer: De chondroitin ut faciam investigationis insinuat quod propagationem vel coetus prostate cancer. Hic effectus non chondroitin sulfate ostensum est cum supplemento. Sed plus est donec Neque chondroitin sulfate prostatae turpis vel si ad altus periculum excolendo (prostatae turpis habetis patrem aut fratrem).

moderatus

Videte, hoc compositum.

Warfarin (Coumadin)

Warfarin (Coumadin) is tardus autem ad sanguinem clotting. Chondroitin et glucosamine taking Sunt multa tradit ut ostenderet, addit ad effectus ex warfarin (Coumadin) de sanguine clotting. Et hoc non potest esse causa conterendo et sanguinem quia gravis. Noli tu sumis chondroitin warfarin (Coumadin).

Sunt non nota interactions cum herbis et supplements.

Sunt non nota interactiones adsumat.

Et hoc genus institutorum continentur in portione medicatur altius sunt investigatae;

Per os:

• quia OSTEOARTHRITIS: Quod est typical chondroitin sulfate 800-2000 dose unius mg forma dosis aut duo vel tria capta est divisa doses usque ad III annis cotidie.

Impositam super pulchritudinem cutis eius

• quia OSTEOARTHRITIS: A crepito continet L mg / chondroitin Gram de sulfate, XXX mg / glucosaminum de gram sulfate, CXL mg / turpis gram in cartilaginem versae, XXXII mg / gram cypri iam usus est pro ut opus valde pro articulis usque ad VIII weeks.

In musculus infusum;

• quia OSTEOARTHRITIS: Chondroitin sulfate (Matrix) infusum est, aut bis weekly in musculus cotidie ad VI mensibus.

Applicetur ad AB OCULI LANGUORE:

• nam cataractae: Quibus complures diversis oculus guttis, et hyaluronate chondroitin sulfate sodium (DisCoVisc, Alconis habes Laboratories, Viscoat, Alconis habes Laboratories, DuoVisc, Alconis habes Laboratories, Viscoat, Alconis habes Laboratories, Provisc, Alconis habes Laboratories) cataracta sunt usus durante surgery.

Calcium chondroitin sulfate, CDS, Chondroitin, Chondroitin Polysulfate, Chondroitin Polysulphate, chondroitin sulfate A, Chondroitin Sulfates, chondroitin sulfate B, chondroitin sulfate C, Chondroitin Sulphates, Chondroitin Sulphate A Sodium naphthalene, Chondroïtine, Chondroïtine Sulfate A, Chondroïtine Sulfate B, Chondroïtine Sulfate C : IV-Chondroïtine Sulfate, et Chondroïtine 4- 6-Sulfate, Condroitin, CPS, CS, CSA, CSC, IOCUS, Galactosaminoglucuronoglycan Sulfate, Chondroitin sulfas, IV, ac VI-4 Chondroitin Sulfate, Poly- (1-> III) Aceltyl Amino-N-II-II-III-Deoxy,-o-D-Glucopyranurosyl Beta-4-(vel 6), de Polysulfate Chondroïtine, Sulfate de Chondroïtine, Sulfate de Galactosaminoglucuronoglycane, de Chondroïtine Sulfates; Sulfato de Condroitina .

Ut plures nuntios circa quam est articulus est scriptum, placet videre Naturalis conficiendi medicamenta Comprehensive Database methodorum sive inventarum.

1. Bruyère Domine, Honvo G, N flos Veronensum depereunt, et al. OSTEOARTHRITIS de genu administratione commendaticiis algorithm An updated per a Societas Europae Volume et in Economic rationibus Osteoporosis, imperfecta, et Musculoskeletal Morbus (ESCEO). Arthritis Semin pituitae cursus finiatur. Dec MMXIX: XLIX: 337-50. View abstracto.
2. Navarro S: Et separabis L, I. KR, Marcus Lampe, Hullar Maj. E nervis ac crebritate modulorum suaviorem Microbiota per Glucosamine Chondroitin in randomized, Tentatio duplex caecus nauclerus apud homines. Micro-organizati. MMXIX Nov XXIII: VII. pii, E610. View abstracto.
3. DE Restaino, Finamore R: A Stellavato, et al. Europae chondroitin sulfate et glucosamine Supplementis, cibum, qualitas et quantitas census Systematica veneficiis comparari. Carbohydr polym. Oct MMXIX XV, CCXXII: (CXIV)CMLXXXIV. View abstracto.
4. Kolasinski S, T Neogi: Regina Hachbergensis, et al. MMXIX American College of Rheumatology / arthritis de administratione ratio, Foundation of OSTEOARTHRITIS de parte, coxae et genu. Rheumatol arthritis. Feb MMXX, LXXII, 220-33. View abstracto.
5. Savarino V, Pacaeus F2, Scarpignato C; Esoxx Study Group. Randomized Volume iudicium: mucosal et acidum praesidium combined per suppressio morbo curatio est non-refluxus erosiva - Esoxx efficaciae est, chondroitin sulphate hyaluronic acidum-fundatur bioadhesive soliditas. Pharmacol alimentum, patris. MMXVII: XLV: 631-642. View abstracto.
6. Goddard C, Janssen MONEDULA. Recurrentes tractus urinarii Infectiones et acido Hyaluronic Intravesical chondroitin sulfate: systematicam review meta nibh. Iul Int Urogynecol J. MMXVIII: XXIX: 933-942. Nov 27, Review Epub MMXVII. View abstracto.
7. T Iannitti: Morales-Medina C, A Merighi, et al. A hyaluronic acid- medicinae fabrica quod secundum chondroitin sulfate melius GASTRITIS, dolor, molestiae et endoscopic features. Res medicamento Deliv Transl. Oct MMXVIII, VIII, 994-999. View abstracto.
8. A Tsuruta, Horiike T, M Yoshimura, Nagaoka I. volutpat ex quibus effectus de administratione de glucosaminum in supplementum biomarkers enim metabolismi in cartilaginem versae dignissim id histriones: A randomized sobrie duplex caecus studio placebo. Mol Biol Rep. Oct MMXVIII: XVIII: 3941-3948. Aug 17 Epub MMXVIII View abstracto.
9. Simental Mendía-M, Sanchez García-A, Vilchez Cavazos-F: CA Darius Acosta, Olivo: Pena, Martínez VM, Simental Mendía-LE. Chondroitin et glucosamine OSTEOARTHRITIS de genu effectus sulfate in signa: systematicam review analysis de randomized, placebo-sobrie meta ac iudiciis. Rheumatol Int. Aug MMXVIII: XXXVIII: 1413-1428. Iun 11 Review Epub MMXVIII. View abstracto.
10. Vestibus amicire, T, V Ideno: Fórum: M; et al. Glucosaminum effectis in aegris cum OSTEOARTHRITIS de genu: systematicam review et meta-analysis. Clin Rheumatol. Sep MMXVIII: XXXVII: 2479-2487. Apr 30, Epub MMXVIII View abstracto.
11. Victoria PYO, Cho WJ. Et Meta-analysis of Nomina Systematica Review Intravesical Hyaluronic Acid et Hyaluronic Acid / chondroitin sulfate per insinuationem Interstitial Cystitis / Qui mortem Morbositates vesicae syndrome. Cell physiol Mol. MMXVI, XXXIX, 1618-25. View abstracto.
12. Lopez HL, similes Ziegenfuss TN, J. Park volutpat BioCell Collagen est ex effectibus, a Latin Edition Karthaginis Fruit Extract, Ex Exercise Recuperatio Eget et in connectivum TEXTUS suscipite. Integr med (Encinitas). MMXV: XIV: 30-8. View abstracto.
13. Pérez, Balbuena AL abscissi, Tabares C. Ochoa, Belalcazar Kessinger-S, et al. De efficacia eiusdem operis iusta combination 0,09% Prunus / 0.1% chondroitin sulfate libera nos polyethylene glycol conservativam / propylene glycol siccis oculis in cadaveribus morbo: a randomized dispensata iudicio multicenter. Acta Ophthalmol. Sep MMXVI: XVI: CLXIV.View abstracto.
14. Zeng C, J Wei Li S, et al. Glucosamine salutem efficacia, Chondroitin duo coniuncta in tractatione celecoxib imperfecta aut genu. Sci Rep. MMXV: V: (XVI)DCCCXXVII. View abstracto.
15. Romani, Blas JA Castañeda S: Pernaute Sánchez, Domine, et al. In nigredine mixta amet chondroitin sulfate et superioritatis super Glucosamine Sulfate intuentium offuscat Locus enim est reductionem in aegroti et incurvato genu iuncturam dolorem et Eget Impairment imperfecta: A-Sex mense multicenter, Randomized, duplex caecus, placebo-sobrie Fusce Triatio. Rheumatol arthritis. MMXVII, LXIX: 77-85. View abstracto.
16. Pelletier JP, Raynauld JP, AD Bello Loco, et al. OSTEOARTHRITIS de genu celecoxib versus chondroitin sulfate efficacia usura fabrica mutationes RMN: a II-anni studium multicentre exploratory. Res arthritis, patris. MMXVI: XVIII: CCLVI. View abstracto.
17. Singh JA Noorbaloochi S, MacDonald R: Ave n. Chondroitin quia OSTEOARTHRITIS. Cochrane Database Syst MMXV Ian XXVIII, Apoc: I: CD005614. View abstracto.
18. Bruyere O, C Cooper, Pelletier JP, et al. Fusce ut dicitur in ceterorum assensum Societas Europae et Economic rationibus Osteoporosis et imperfecta (ESCEO) algorithm pro administratione OSTEOARTHRITIS de genu-quod-a-vita secundum vera medicina ad occasum. Arthritis Semin pituitae cursus finiatur. MMXVI, XLV (Suppl IV): S3-11. View abstracto.
19. Reginster JY, Dudler J, Blicharski T, Pavelka gradus K-pharmaceutical chondroitin sulfate quasi effective manifestant signa quod genu celecoxib et superior ad placebo in OSTEOARTHRITIS et chondroitin versus versus celecoxib Locus (INTEL CONCEPTO). Ann Reum disp. May 22. pii MMXVII: annrheumdis, 2016-210860. View abstracto.
20. N. chondroitin sulfate apparatu volpi qualitate diversae operationes ordinatas ad medicinam. J pharm Pharmacol MMIX: LXI: 1271-80. View abstracto.
21. Lauder RM. Chondroitin sulphate, et universa moleculo est potentiale impingit in a lateque de biologicum systems. Ibi complement med MMIX: XVII: 56-62. View abstracto.
22. C. Barnhill tristibus, Væ CL, & Williams DW, Reda Song: Cicero, CL, Clegg erit. Chondroitin et glucosamine, quia selectio uber / chondroitin arthritis iudicium interveniret. Ego sum pharm Assoc MMVI: XLVI: 14-24. View abstracto.
23. Zegels B, P Crozes, Uebelhart D, Bruyere Domine, Reginster JY. Est ratio de uno dose (mg forma MCC) comparari simul in tres-dies dose (mg forma CD) de VI & sulfate in IV chondroitin cum aegris genu OSTEOARTHRITIS. A randomized sobrie duplex caecus studio eventus placebo. Osteogenesis imperfecta Karthaginis MMXIII: XXI: 22-7. View abstracto.
24. M. Vigan allergic DERMATITIS contactus fecit per chondroitin sulfate sodium crepito insum a medicamine. Dermatitis MMXIV, LXX: 383-4. View abstracto.
25. Torella M: MT Ciceronis Schettino Salvatore S: Serati M: P De Franciscis, Colacurci N. Intravesical Lorem, in CYSTITIS recurrentes: a multi-centrum experientia. J Infect Chemother MMXIII: XIX: 920-5. View abstracto.
26. Cicero, H, E Maheu, qui occupet locum M. INDICIUM immutatione effectus, OSTEOARTHRITIS de genu in chondroitin sulfate: a meta randomized, placebo-sobrie analysis de iudiciis sunt praestiterit structum (®). J. aperta Rheumatol MMXII, VI, 183-9. View abstracto.
27. Rectangulum ^ B, Merighi A, D Corbascio, Rottigni V, Fistetto G, Esposito A. certa hyaluronic compositum de acidum, chondroitin sulphate, et in randomized oris formula duplex caecus, placebo treatment of dispensata studiis ad symptomata in patientibus non-erosiva gastroesophageal refluxus. Eur med Pharmacol Sci MMXIII Ap: XVII: 3272-8. View abstracto.
28. Llamas Moreno, JF, Baiza Durán, LM, Rodriguez-Saucedo LR Alaníz De-la C. o. Virtus et salus chondroitin sulfate / Prunus versus polyethylene glycol / propylene glycol / hydroxypropyl guar in siccis oculis aegris. Clin Ophthalmol MMXIII: VII: 995-9. View abstracto.
29. De Vita D, H Antell, Giordano S. efficacitati intravesical hyaluronic acidum Bacteria CYSTITIS in adulta recurrentes, cum aut sine chondroitin sulfate ad mulieres: a meta-analysis. Int J Urogynecol MMXIII: XXIV: 545-52. View abstracto.
30. Nonnullæ C, D. Crew, Shao T, G Kranwinkel, Kalinsky K, M Maurer, Brafman L, B Felicitas, Tsai WY, Hershman DL. II chondroitin et glucosamine tempus studio in communem symptoms in mulieres cum pectus cancer aromatase inhibitor-consociata. Care Cancer support MMXIII: XXI: 1077-87. View abstracto.
31. M Fransen, Agaliotis M, Aberdonensi L, M Votrubec, Bridgett L. Su S, S Ian: Aprilis I, J Longus, R Sulpicius Severus, Woodward M, R dies; LEGS studere 'on coetus. Chondroitin et glucosamine OSTEOARTHRITIS de genu: a randomized duplex caecus, placebo-sobrie iudicium orci dispensantem singula et coetus experiundo regimens. De Dis Romanorum Ann Reum MMXV: LXXIV: 851-8. View abstracto.
32. Provenza M, Shinjo SK, JM Silva Critica: et regnat Per CR, Rocha FA aequalem. Morbi chondroitin et glucosamine sulfate semel vel pluries, in AAS providet amet genus pertinere imperfecta. Clin Rheumatol MMXV: XXXIV: 1455-62.View abstracto.
33. J Von Felden, composita Montanos M, Kessebohm K, F. Nocte Diei Stickel Mauris effecerunt Hepatitis, post acuti iecoris injuria imitantur autoimmune attractio puritate alimentorum supplemento chondroitin et glucosamine quibus sulfate. Int J Clin Pharmacol Ibi MMXIII: LI: 219-23. View abstracto.
34. Hachbergensis MC, Martéllum exarsísset-Pelletier J, Monfort J: Moller Ego Castellae M, arden N, Berenbaum F, Blanco Thomas, Conaghan PG, Domenech G, Henrotin ego, Pap T, Richette P: Sawitzke A, du Souich P, Pelletier JP ; pro investigatione sapienter iactibus uti Group. Chondroitin et glucosamine sulfate `Combinatae quaevis ad OSTEOARTHRITIS dolore genu: et multicentre, randomized, geminus-cæcus, non-iudicium inferior versus celecoxib. Ann Reum MMXVI Ditis; LXXV 37-44. View abstracto.
35. Cerda C, M Bruguera, consociata cum pares A. Hepatotoxicity et glucosamine chondroitin sulfate patientibus longos iecoris morbo. J mundo Gastroenterol MMXIII: XIX: 5381-4. View abstracto.
36. Ille sono G, Gregorius M, Stacey Quaestiones de M. texturis. 1. Chondroitin ex cartilagine conectitur. J Biol MCMXLIV: XXXVIII: 142-146.
37. FDA. Approbatio Premarket (Magnae Matris). Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=20196.
38. FDA approbatione est Viscoat premarket concedit. Safety Biomed Signa MCMLXXXVI: XVI: LXXXII.
39. Blotman Loyau F G. et C. et iudicium chondroitin sulfate in gonarthrosis [Abstract]. Osteogenesis imperfecta MCMXCIII Cart: I: LXVIII.
40. A. Adebowale Cox DENZ.-Liang Z Eddington ND. Glucosaminum et analysis of venalicium per chondroitin sulfate contentus products et rudis materiae caco-II permeability de chondroitin sulfate. Ego sum nutraceutical Assoc. MM, III, 37-44.
41. Et Pavelka et al. Geminus-caecorum effectus consectetuer oris studio & CS IV VI 1200mg, 800mg, contra 200mg in placebo treatment of OSTEOARTHRITIS femorotibial. Liter Wular Rheumatol MCMXCVIII, XXVII (suppl II) LXIII.
42. L'Hirondel JL. [Volume duplex caecus studio, cum ab oris chondroitin sulfate applicationem ad vs. placebo treatment of tibio femoris gonarthrosis in aegris CXXV]. Litera Rheumatologica MCMXCII, XIV, 77-84.
43. Quæ carnis sunt, AM Merlini C, A Imhoff; et al. A unus-anno randomized, duplex caecus, placebo-sobrie studiis et in oris chondroitin sulfate cum aegris genu OSTEOARTHRITIS. Et imperfecta Karthaginis MCMXCVII: V: LXX.
44. Et Chantraine Uebelhart D Insecta intracellulare A. du sulfate chondroitine de la gonarthrose: en geminus-Insecta randomisee insu versus placebo [Abstract]. Rev.Rhumatisme MCMXCIV: X: DCXCII.
45. Carwood G., Goemaere, S., et Veys Results for M. chondroitin sulfate, S / DMOAD (structure /, cum inflexo morbum anti-medicamento OSTEOARTHRITIS) in curatio de digito iuncturam OA. Osteogenesis imperfecta Karthaginis MCMXCVIII, Suppl A VI: 37-38. View abstracto.
46. Nakazawa, K., Murata, K., Izuka, K., et Oshima, Y graeci brevis-term effectus in coronarius atherosclerotic chondroitin sulfates A et C in subditis et ad suas actiones anti-thrombogenic. J Jpn.Heart MCMLXIX: X: 289-296. View abstracto.
47. Nakazawa, et Murata K, K Fungi ex effectis isomers in atherosclerotic chondroitin sulfate uelle. ZFA. MCMLXXIX, XXXIV, 153-159. View abstracto.
48. Thomasius, G. [XXXV A studio casibus de SULPHURATUS acidum chondrotiine Arthrosis sunt tractata (transl auctor est)]. Praxis Schweizerische Rundschau furrure Medizin 12-27-1977: LXVI: 1696-1699. View abstracto.
49. Embriano, P. J. Postoperative post phacoemulsification patientes coactus, chondroitin sulfate sodium, sodium sodium hyaluronate vs. hyaluronate. Ann.Ophthalmol. MCMLXXXIX, XXI, 85-88, 90. View abstracto.
50. Railhac, JJ, Zaim, M., Saurel, AS, Pandura, J. et Fournie, B. XII mensibus Effectus curatio cum chondroitin sulfate in cartilaginem versae sunt in volumine OSTEOARTHRITIS aegris genu: a randomized, duplex caecus, placebo-sobrie gubernatori MRI studiis usus. Clin.Rheumatol. MMXII: XXXI: 1347-1357. View abstracto.
51. De Vita Et D. Giordano, S. efficacitati intravesical hyaluronic Acidum / chondroitin sulfate, in CYSTITIS bacterial recurrentes: a randomized studium. Int.Urogynecol.J. MMXII, XXIII, 1707-1713. View abstracto.
52. Nickel, C, Hannonem, Poenorum ducem, P., Saint, K., et Thomam, H. secundi multicenter, randomized, geminus-caecorum parallel-efficaciam et salutem coetus est iudicium chondroitin sulfate sodium intravesical autem comparari existentia in subiectis imperium vehiculum ullo conatu sedentes in interstitialibus CYSTITIS / vesicae dolorem syndrome. Urologia MMXII: LXXIX, 1220-1224. View abstracto.
53. Yue, J., Yang, M., Yi, S., Dong, B. Li, W. Yang, A., Lu, J., Zhang, R., et Sicardi, J. chondroitin sulfate et / vel glucosaminum hydrochloride Kashin-Beck morbo,-botrus randomized, placebo-sobrie studiis. Osteoarthritis.Cartilage. MMXII, XX, 622-629. View abstracto.
54. Kanzaki famulam tuam N., Saito, K, Maeda, A., Kitagawa, Y., Kiso, Y., Watanabe, K, Tomonaga, A., Nagaoka, I., et Yamaguchi, de puritate alimentorum supplementum H. Effectus glucosaminum quibus dose, chondroitin sulfate et quercetin glycosides OSTEOARTHRITIS de genu signa: a randomized, duplex caecus, placebo-sobrie studiis. J.Sci.Food Agric. 3-15-2012: XCII, 862-869. View abstracto.
55. Wildi LM Raynauld, JP, Martéllum exarsísset-Pelletier, J., Bello, A., Bessette, L., Morin, G. timere Abram, P., Dorais: M. et Pelletier, JP Chondroitin sulphate reduces volumen et cartilagine conectitur et medullae damnum laesiones in aegris genu OSTEOARTHRITIS incipiens quasi mane VI menses post initium Lorem: a randomized, duplex caecus, placebo-sobrie usus gubernatori studium MRI. Ann.Rheum.Dis. MMXI, LXX: 982-989. View abstracto.
56. Damiani moraturae, R., Quarto, G.: Bava, I., Ucciero, G., De: Domenico R., Palumbo, ML, Autorino, R. Ne recurrentes, urinariorum tractu infectiones a intravesical administrandae hyaluronic Acidum chondroitin et sulphate : placebo-sobrie a randomized iudicio. Eur.Urol. MMXI, LIX, 645-651. View abstracto.
57. Zhou q Chen, H., Regina, M. Wang, Q., Yang, L. et Xie, L. Development in cornea exemplum facti novam gustaverunt ex vivo fungal adhaerentiam. Graefes Arch.Clin.Exp.Ophthalmol. MMXI, CCXLIX: 693-700. View abstracto.
58. Liesegang, J. J. Viscoelastic deo substantias ecclesiasticus ophthalmology. Surv.Ophthalmol. MCMXC, XXXIV, 268-293. View abstracto.
59. Furer, V., Claudio, L. R. et Pillinger, M. H. Bilateral pinna CHONDRITIS initiation supplementum antecedentibus glucosaminum chondroitin. Scand.J.Rheumatol. MMXI: XL: 241-243. View abstracto.
60. Chen W. C., Yao, C. L., Chu, M. I., et Wei: V. H. Compare effectis chondrogenesis in cultura de variis hominum genus super cellas mesenchymal derivantur C. J.Biosci.Bioeng chondroitin sulfate. MMXI, CXI, 226-231. View abstracto.
61. Kato, D., Aevo S., Watanabe, I., Arihara, M., Sugiura famulam tuam N., Kimata, K, Suzuki, Y., Morita K Hidari, KI, et Suzuki Herpesvirus hominis T- operatio autem chondroitin sulphate E targeting dengue virum protein. Herpesvirus hominis Res. MMX: LXXXVIII: 236-243. View abstracto.
62. Wandel, S., Juni, P., tendal, B., Nuesch, E., Villiger, PM Welton, Londini: Reichenbach, S., et Trelle: S. Effectus glucosaminum, chondroitin vel placebo in aegris cum OSTEOARTHRITIS in coxae et genu: network meta-analysis. BMJ MMX, CCCXLI, c4675. View abstracto.
63. Rentsch, C., Rentsch, B., Breier, A., Spekl, K, Jung, R., Manthey, S., Scharnweber, D., Zwipp, H. et Biewener: Os A.-Long critical- magnitudine defectui tractata cum tEXTUS, polycaprolactone machinatum, co-lactide scaffolds: gubernatori studium sit super mures inclusi essent. J.Biomed.Mater.Res.A 12-1-2010: XCV, 964-972. View abstracto.
64. Ave, A. R., Park, M. et Kim: Liliaceae V. S. Ex huso suppone, et talis viros chondroitin sulfates (Acipenser sinensis) et effectus, ex in incrementum fibroblasts. Biol.Pharm.Bull. MMX, XXXIII, 1268-1273. View abstracto.
65. Sawitzke, AD, Shi, H., Finco MF dirigamur, DD, Cicero, CL Cantor, NG, MG Bradley, JD: Argentum, D., Jackson, CG, lane, NE, Oddis, CV, Wolfe, M. , lisse, J. Furst dE Bingham CO Reda, DJ HTML, RW Williams HJ et SCHLINK DO Fusce salutemque virtute glucosaminum, chondroitin sulphate et coetus vel placebo celecoxib imperfecta ad agendum in genu: II annorum ex pede. Ann.Rheum.Dis. MMX, LXIX, 1459-1464. View abstracto.
66. Nickel, C, Egerdie, RB, Steinhoff, G.: Cicero, B., et Hannonem, Poenorum ducem, P. multicenter, randomized, geminus-caecorum parallel coetus iudicium gubernator efficaciae chondroitin sulfate sodium et salus intravesical versus est in potestate vehiculo CYSTITIS interstitialibus cum aegris / vesicae dolorem syndrome. Urologia MMX: LXXVI: 804-809. View abstracto.
67. Moller, I. Phares, M., Monfort, J., Benito, P., Cuevas, J., Perna, C., Domenech, G.: Herrero, M., Montell, E., and; utiq; J. OSTEOARTHRITIS de genu efficaciam chondroitin sulphate in aegris cum adsint et PSORIASIS: a randomized, duplex caecus, placebo-sobrie studiis. Osteoarthritis.Cartilage. MMX, Suppl XVIII I, S32-S40. View abstracto.
68. EGUIGUREN, Garcia, A. G.; utiq; J., Montell, E, et Lopez, M. G. Antioxidante, et antiinflammatory neuroprotective ex actionibus et proteoglycans chondroitin sulfate. Osteoarthritis.Cartilage. MMX, Suppl XVIII I, S24-S27. View abstracto.
69. Hachbergensis M. C. Libri de immutatione effectus, OSTEOARTHRITIS de genu in chondroitin sulfate: an updated meta randomized, placebo-sobrie analysis de iudiciis in II-annus tempus. Osteoarthritis.Cartilage. MMX, Suppl XVIII I, S28-S31. View abstracto.
70. Imada, K., Oka, H., Kawasaki, D., Miura famulam tuam N., Sato, T., and Iuli, A. actio anti-cuidam arthritico dubie, viae in hominem naturalem chondroitin sulfate articularis Chondrocytes vagina synovialis et fibroblasts. Biol.Pharm Fr. MMX: XXXIII: 410-414. View abstracto.
71. Pavelka, K., Coste, P., Geher, P., and Krejci, G. operationes efficaciam et salutem de CCC piascledine versus chondroitin sulfate per menses curatio plus II menses VI observationis cum aegris apud OSTEOARTHRITIS de genu. Clin.Rheumatol. MMX: XXIX: 659-670. View abstracto.
72. Quamplurima S. E., Pelletier, J. P, Mineau, P., Imago tuarum N. et Martéllum exarsísset-Pelletier, J. variabilis III diversis effectus in humanum osteoarthritic chondroitin sulfate suis Revolutionibus componit in cartilaginem versae / Chondrocytes: relevance praecelsa puritatis et productio processus. J.Rheumatol. MMX: XXXVII: 656-664. View abstracto.
73. Lane, S. S., Wichita, W. D.: Kullerstrand L. J., Knauth, K., et Lindstrom, R. L. FUTURUS ex comparatione operum quae edit Occucoat, Viscoat et Healon et endothelial cellam damnum de intraocular pressura. J Refract.Surg Cataractam praeterfluit. MCMXCI: XVII: 21-26. View abstracto.
74. Jackson Ibid plaas, AH, Sandy, JD, Hua, C., Kim-Rolands, S., Barnhill, G.: Cicero, CL, & Clegg, et fremuerunt Farmacocinética humani oris ingestion glucosamine, et seorsum singulis sive omnibus chondroitin sulfate tandem coniunctim afficient vniuersa. Karthaginis MMX imperfecta: XVIII: 297-302. View abstracto.
75. Nigrum, C., Clar, C.: Catullus, R., MacEachern, C., McNamee, P., Quayyum, Z., Royle, P., et Thomam, S. chondroitin et glucosamine Supplementis et orci in efficaciam ex retardatione quin caperet neque progressum OSTEOARTHRITIS de genu: systematicam review and economic iudicium. Salutem Technol.Assess. MMIX: XIII: 1-148. View abstracto.
76. Sasisekharan, R. Et Shriver, I. De discrimine est opportunitas: et perspective in heparin discrimine. Thromb.Haemost. MMIX, CII, 854-858. View abstracto.
77. Crowley, DC, Lau, FC, Sharma, P., Evans, M., Guthrie famulam tuam N., Maradona, M., Maradona, D., Day, DK, & Raychaudhuri, SP Safety & efficacia collagen in undenatured type II in treatment of OSTEOARTHRITIS de genu: et orci iudicium. Int.J.Med.Sci. MMIX, VI, 312-321. View abstracto.
78. Rainsford, E. D. simul causa et quod a pharmaceutical compositionem pharmacological studiis ac orci iudiciis in genere et alia efficaciam ex chondroitin sulphate glycosaminoglycans: Censura. J.Pharm.Pharmacol. MMIX: LXI: 1263-1270. View abstracto.
79. Hauser, J. P, Buethe, D. A., Califano, J., Sofinowski, M., T., Culkin, D. J. et Hurst, R. E. restitueret obice urinaria ex vitiato muneris acidum intravesical chondroitin sulfate. J.Urol. MMIX, CLXXXII, 2477-2482. View abstracto.
80. Kubo, M., aaa, K., Mimura T. Matsusue Y. et mori, ad treatment of coxae et genu C. chondroitin sulfate OSTEOARTHRITIS: current et statum futurum trends. Sci. 9-23-2009: LXXXV (13-14) 477-483. View abstracto.
81. Lee, M. H., Woo, J. H. Choi, S. J., ji, D. J., and Song: G. et G. effectum conflictus glucosaminum chondroitin sulfate ex OSTEOARTHRITIS progressum: a meta-analysis. Int Rheumatol MMX, XXX, 357-363. View abstracto.
82. Souich Du P, Garcia, A. G.; utiq; J. et Montell, C. immunomodulatory et anti-inflammatione effectus est chondroitin sulphate. J.Cell Mol.Med. MMIX, XIII (8a) 1451-1463. View abstracto.
83. Fthenou, E., Zong, P., Zafiropoulos, A., Dobra, K., Hjerpe: A. et Tzanakakis, chondroitin sulfate X. A G. rectificet fibrosarcoma cellula adhaesionem parit, Phaeodactylum tricornutum et transitus per tyrosine enzyme signalling jnk et tractuum. In MMIX Vivo: XXIII: 69-76. View abstracto.
84. Bhattacharyya, S., Solakyildirim, K Zhang, I. Chen, LM, id Linhardt, RJ, et Tobacman JK tenetur Cell-II-VIII crescit in ramos bronchiales epithelial cellulis, post arylsulfatase silencing ex B venire facias chondroitin in-4- sulfate. Am.J.Respir.Cell Mol.Biol. MMX: XLII: 51-61. View abstracto.
85. Schulz, A., Vestweber, A. M., and Acuña, D. [Anti-inflammatory actionem hyaluronic acidum, chondroitin sulfate curriculum exemplar urinaria est in vitro diffunduntur]. Aktuelle Urol. MMIX: XL: 109-112. View abstracto.
86. David, Raoudi, M., Deschrevel, B., Turner, S., Galera, P., Boumediene, K., et Fulgoni, JP chondroitin sulfate hyaluronan productio crescit ab humana ordinacione hyaluronan synthases synoviocytes differentiale per: Munus, et p38 Art. Rheum arthritis. MMIX: LX: 760-770. View abstracto.
87. Matsuno, H., Nakamura, H., Katayama, K., Hayashi, S.: Dona Nobis Pacem: S., Yudoh, K., et Kiso, M. Effecta, chondroitin et glucosamine, oralis administratione quercetin glucosidum de vagina synovialis umor in aegris cum proprietatibus OSTEOARTHRITIS et rheumatoid arthritis. Biosci.Biotechnol.Biochem. MMIX, LXXIII, 288-292. View abstracto.
88. Kahan, A., Uebelhart, D., De, Vathaire F. Delmas, P.D. et Reginster, J. M. sulfate Long-term effectus ex chondroitins IV et VI OSTEOARTHRITIS de genu et in studiis progressum, ne OSTEOARTHRITIS est, duo-annus randomized, duplex caecus, placebo-sobrie iudicium. Rheum arthritis. MMIX: LX: 524-533. View abstracto.
89. Rovetta, G. Galactosaminoglycuronoglycan sulfate (matrix) Lorem in in articulatio tibiofibularis OSTEOARTHRITIS de genu. Res Medicinae Exp Clin MCMXCI: XVII: 53-57. View abstracto.
90. Oliviero, II, Sorrentino, G., De Paula P., Tranfaglia, E, D Alessandro, A., Carifi, S., Porfido, FA contentum, Cerio, R., Grasso, AM, Policicchio, D., et . Matrix effectus in curatio est super senes populi cum inveterata articularis degeneratum. Res Medicinae Exp Clin MCMXCI: XVII: 45-51. View abstracto.
91. Bruyère, O., Burlet famulam tuam N., Delmas, P. D.: Nabu Press, R., Cooper, C., et Reginster, J. de M. Aestimatio signa tardus ratio agendi medicamento in ORDO OSTEOARTHRITIS est usus. BMC.Musculoskelet.Disord. MMVIII: IX: CLXV. View abstracto.
92. Theoharides, C. C., Kempuraj, D., Vakali, S., et Cristoferi Colom: G. R. curatio praefracti interstitialibus CYSTITIS / vesicae dolorem syndrome in CystoProtek - oris esse multi-agente naturalis supplementum. J can Urol MMVIII, XV, 4410-4414. View abstracto.
93. Hachbergensis M. C Zhan, M. et Langenberg, declines a rate of P. Vocetur spatium latitudinis aegris apud OSTEOARTHRITIS de genu iuncturam: systematicam review analysis de randomized, placebo-sobrie et meta de iudiciis chondroitin sulfate. Curr.Med.Res.Opin. MMVIII, XXIV, 3029-3035. View abstracto.
94. Sawitzke, AD, Shi, H., Finco MF dirigamur, DD, Byngham, CO, & III: Cicero, CL Cantor, NG, MG Bradley, JD: Argentum, D., Jackson, CG, lane, NE, Oddis, CV Wolfius etiam P., lisse, J., Furst dE Reda, DJ, Moskowitz: RW Williams, HJ, et Clegg, et fremuerunt glucosaminum modum et / vel progressum chondroitin sulfate ex OSTEOARTHRITIS de genu: et fama glucosaminum ex / motu iudicii chondroitin arthritis. Rheum arthritis. MMVIII, LVIII, 3183-3191. View abstracto.
95. Nickel, C, Egerdie, B., Downey, J., Singh, R., Skehan, A., Carrus, L.,-Bird quod Irvine, K, A verus multicentre orci vitae usu in studio penitus efficaciae nulliusque ponderis iustis aestimare salutem ex quibus cetera interstitialibus CYSTITIS sulphate intravesical chondroitin. BJU.Int. MMIX, CIII, 56-60. View abstracto.
96. Nordling, J. et prima signa Ophoven A. Intravesical glycosaminoglycani replenishment chondroitin et sulphate potest in CYSTITIS formae. A multi-nationalibus: multi-media, observational orci iudicium futurum. Arzneimittelforschung. MMVIII: LVIII: 328-335. View abstracto.
97. Theocharis D. A. Skandalis S. S. Noulas A. V. Papageorgakopoulou N. Theocharis A. D. Karamanos et N. et C. Hyaluronan chondroitin sulfate proteoglycans supramolecular in organizationem corporis vitrei animantibus. Res Connect.Tissue. MMVIII: XLIX: 124-128. View abstracto.
98. Fosang, et Parva J. A., B. Law C. omni sensu: ut aggrecanases therapeutica peltas pro OSTEOARTHRITIS. Nat.Clin.Pract.Rheumatol. MMVIII, IV: 420-427. View abstracto.
99. Praveen, R. M., Koul, A., Vasavada, A. R., Pandita, D. Dixit N. V. et Dahodwala, F et F versus DisCoVisc mollis testam, et Viscoat usura ars Provisc in phacoemulsification: randomized Volume iudicium. J.Cataract Refract.Surg. MMVIII, XXXIV, 1145-1151. View abstracto.
100. Dudics, V.: Kunstar, A., Kovacs, J., Lakatos T. Geher, P., Gomor, B., Monostori, E., and Uher, P. Chondrogenic mesenchymal caule cellulis potentiale de aegris rheumatoid OSTEOARTHRITIS et arthritis, in mensura microculture ratio. Cellulae Tissues.Organs MMIX: CLXXXIX, 307-316. View abstracto.
101. Porru, D., Cervigni M. Nasta, L., Natale, Franciscus: Ecce venio: Voi R., Tinelli, C., Gardella, B., Anghileri, A., Spinillo, A., quaque Roveretum, B . Results of endovesical hyaluronic acidum / chondroitin sulfate in curatio de Interstitial Cystitis / qui mortem Morbositates vesicae syndrome. Rev.Recent Clin.Trials MMVIII, III: 126-129. View abstracto.
102. Cervigni, M., Natale, P., Nastae L., Padoa, A., Voi, L. R. et Porru, A D. Lorem intravesical combined per hyaluronic Acidum chondroitin et verterunt ad vesicae dolorem syndrome / interstitialibus CYSTITIS. Int.Urogynecol.J.Pelvic.Floor.Dysfunct. MMVIII: XIX: 943-947. View abstracto.
103. Zhang, W., Moskowitz: RW Nuki, G.: Abramson, S., Altman, RD, arden famulam tuam N., Bierma, Zeinstra, S., Brandt, KD, Croft, P., Doherty, M., Dougados , M., Hachbergensis M. Hunter, DJ, Kwoh, K., Nilsson, eadem LS, ac Tugwell P. OARSI suasiones ad coxae et genu procuratio of OSTEOARTHRITIS, Pars Secunda: OARSI, secundum quod velle, volui consensus guidelines. Osteoarthritis.Cartilage. MMVIII: XVI: 137-162. View abstracto.
104. Rainer, G.: Stifter, E., Luksch: A. et Menapace, R. comparatione ad effectum de intraocular pressura post postoperative in DuoVisc Viscoat et parvum, cataracta, incidendum surgery. J.Cataract Refract.Surg. MMVIII, XXXIV, 253-257. View abstracto.
105. Laroche, L., Arrata, M., Brasseur, G.: Lagoutte, F. Le Mer, Y., Lumbroso, P., Mercante, M.: Linnaeus, P., Rigal, D., Roncin: S. , et . [Curatio arida oculus syndrome est superior gel: a randomized studio multicenter]. J Fr.Ophtalmol. MCMXCI, XIV, 321-326. View abstracto.
106. Conte, A., de Bernardi, M., Palmieri, L., Lualdi, P., Mautone, G., et Ronca, G. metabolicae fata virum in exogenous chondroitin sulfate. Arzneimittelforschung. MCMXCI, XLI, 768-772. View abstracto.
107. Bana, G.: Jamard, B., Verrouil, E., and Mazieres, B. procuratio of coxae et genu in chondroitin sulfate OSTEOARTHRITIS: an overview. Adv.Pharmacol. MMVI: LIII: 507-522. View abstracto.
108. Mazieres, B., Hucher, M., Zaim: M. et Garnero P. chondroitin sulphate effectum conflictus apud OSTEOARTHRITIS signa genu: et multicentre, randomized, duplex caecus, placebo-sobrie studiis. De Dis Romanorum Ann Reum MMVII: LXVI: 639-645. View abstracto.
109. Ortelius, A. W., Volcanus, M. G., Armstrong, J. W. et Jacks, D. D. Quod autem effectus chondroitin sulfate indices suppletionem est ex exercitium brachium musculus damnum adductus excentricis. J.Sports Med.Phys.Fitness MMV: XLV: 553-560. View abstracto.
110. Michel, BA, Stucki, G., Frey, D., De, Vathaire F. Vignon, L., Bruehlmann, P., and Uebelhart: IV et VI D. Chondroitins sulfate in OSTEOARTHRITIS de genu: a randomized, sobrie iudicii. Rheum arthritis. MMV: LII: 779-786. View abstracto.
111. Rovetta, G.: Monteforte, P., Molfetta, G., et Balestra: V. A duorum annorum studio chondroitin sulfate erosiva apud OSTEOARTHRITIS de manibus: et mores erosions, osteophytes, et manus dolor Praesent. Res Medicinae Exp Clin MMIV: XXX: 11-16. View abstracto.
112. Matheus, P. [Radiological progressum est internum, femoro gonarthrosis tibiae apud OSTEOARTHRITIS. Chondro, tutela effectus ex ACS4 sulfates, chondroitin ACS6]. Presse Med 9-14-2002: XXXI: 1386-1390. View abstracto.
113. Volpi: X. De Orat bioavailability chondroitin sulfate (Condrosulf) In partesque eius quales sint sanus masculum voluntariorum fuit. Osteoarthritis.Cartilage. MMII: X: 768-777. View abstracto.
114. Rovetta, G. Monteforte, P. Molfetta G. et Balestra V. Chondroitin sulfate erosiva imperfecta in manus. Int J textus agere. MMII: XXIV: 29-32. View abstracto.
115. Steinhoff, G., et Thacasin: B. et Rowan Rowan, chondroitin sulfate Quae quidem S. de 0,2% in CYSTITIS interstitialibus. J can Urol MMII, IX, 1454-1458. View abstracto.
116. O'Rourke, chondroitin et glucosamine M. praefixio efficacia, quia OSTEOARTHRITIS. Pract nutrix MMI, XXVI, 44-52. View abstracto.
117. [Prodest effectus doloris et facies anterior munus in in de CD Chondrosulf Arthrosis: a meta-analysis]. Presse Med MM: XXIX (Suppl XXVII), 19-20. View abstracto.
118. [Multicenter studio Europae et efficaciam in chondroitin sulfate in gonarthrosis: novus vultus ad diam et radiologic eventus]. Presse Med MM: XXIX (Suppl XXVII), 15-18. View abstracto.
119. Alekseeva L. I., Benevolenskaia L. I., Nasonov Results for L., Chichasova: V. N., et Kariakin, A. N. [Structum (chondroitin sulfate) - novum curatio est ex agente Osteogenesis imperfecta]. Ter.Arkh. MCMXCIX, LXXI, 51-53. View abstracto.
120. Schwartz, SR, J. Park BioCell Collagen est Insecta: ad usum eorum hydrolyzed pullum extract pars sternalis cartilagine; facialis microcirculation et auferam sanguinem decorarat atque auxerat, signa canus. Seneca, Lucius Interv Clin. MMXII, VII, 267-273. View abstracto.
121. Schauss AG, Stenehjem J, J Park, Endres M, Clewell A. Effectus autem novus hypothetica pondus humilis pullum hydrolyzed extract pars sternalis cartilaginem versae, BioCell Collagen, ut meliores fiant OSTEOARTHRITIS relatas symptoms: a randomized, duplex caecus, placebo-sobrie iudicium. Victus Cham J Agric. MMXII: LX: 4096-4101. View abstracto.
122. Kalman DS Schwartz III, Pachon J: Gaius E, Almada iniuria. Duplex caecus A randomized Volume iudicium aestimandis gubernator salute et efficacitati hydrolyzed Collagen genus est in adultis et II OSTEOARTHRITIS. Potassium Biology FASEB Acta MMIV, Washington DC, 17-21 Aprilis, MMIV, A90.
123. J; utiq; Montell E, M Herrero, et al. Histopathological clinicis et melioramentis illi cum PSORIASIS oris chondroitin sulfate: uno uiuit felicior sit inventum. Dermatol Online MMV J: XI: XXXI. View abstracto.
124. S Cicero, J sugar, Farber MD. Duorum comparatione operum quae edit viscoelastic agentibus, Healon Viscoat et in postoperative intraocular pressura keratoplasty penetrata. Rentur Surg MCMXC: XXI: 821-6. View abstracto.
125. Zhang YX, Dong W, Liu S, et al. Chondroitin et glucosamine sulfate et effectus in patientibus adulta Kashin-Beck morbo. Clin Rheumatol MMX: XXIX: 357-62. View abstracto.
126. Gauruder Burmester-A, Popken XXIV menses post curatio est nimis excitatus est apud G. Followup urinaria chondroitin sulfate sodium et 0.2%. Aktuelle Urol MMIX: XL: 355-9. View abstracto.
127. Uebelhart D, Knussel Domine, R. Theiler tolerability et efficacia esse ex OSTEOARTHRITIS genu dolorem inferens, in oris AVIARIUS chondroitin sulfate [Abstract]. MCMXCIX schweiz med Wochenschr: CXXIX: MCLXXIV.
128. Leeb BF quandam addidimus, Petera P, C. Results Neumann de studio in multicenter chondroitin sulfate (Condrosulf) usus est in Arthrosis ex corporis membris collegerunt, coxae et genu articulis. Med Wochenschr MCMXCVI Londini: CXLVI: 609-14. View abstracto.
129. Gabay C, Medinger Sadowski, C, D Gasconis, et al. Signa et effectus chondroitin IV et VI chondroitin sulfate OSTEOARTHRITIS de manu: a randomized, duplex caecus, placebo-sobrie iudicium ad unum centrum orci. Rheum arthritis MMXI, LXIII: 3383-91. View abstracto.
130. Yue qequari Strandell J, F. Myrberg Asociación glucosaminum uti potest ad effectum de warfarin potentiale. Cras Center de Universitatis Upsaliensis. Available at: www.who-umc.org/graphics/9722.pdf (Accessed Aprilis MMVIII XXVIII).
131. J Knudsen, Sokol sunt ipfam GH. Glucosaminum potential warfarin commercium, inde auctus gentium in normalized ratione, casu litterae, et de fama et review medwatch database. Pharmacotherapy MMVIII: XXVIII: 540-8. View abstracto.
132. Reichenbach S, R Sterchi, Scherer M, et al. Meta-analysis: chondroitin et coxae quia OSTEOARTHRITIS de genu. Ann Intern med MMVII: CXLVI: 580-90. View abstracto.
133. Alpha SP Mihalko S, M. Loeser, et al. Glucosaminum / chondroitin combined per a genu OSTEOARTHRITIS curatio exercitatio est, aliumque belli studio. Osteogenesis imperfecta Karthaginis MMVII, XV, 1256-66. View abstracto.
134. A. Kahan stopp (studere in Progressione imperfecta Ne) novam duorum annorum iudicii & IV ad VI chondroitin sulfate (CS). Available at: www.ibsa-ch.com/eular_2006_amsterdam_vignon-2.pdf (April MMVII Accessed XXV).
135. J Huang, Olivenstein R, R Taha, et al. Proteoglycan deposuerit in muro atopic asthmatics Airway consectetur. J am Respir Crit Care Med MCMXCIX, CLX: 725-9. View abstracto.
136. Clegg DO, Reda Song: Orff CL et al. Glucosaminum, chondroitin sulfate, et duo in dolore genu combination for OSTEOARTHRITIS. Best J Med N MMVI, CCCLIV: 795-808. View abstracto.
137. Uebelhart D, defectus M, R Marcolongo, et al. OSTEOARTHRITIS de genu intermittentium curatio cum oralis chondroitin sulfate: A unus-anno, Randomize, duplex caecus, placebo multicenter studio versus. Osteogenesis imperfecta Karthaginis MMIV, XII, 269-76. View abstracto.
138. Sakko AJ, Ricciardelli C, K Mayne, et al. Crebritate modulorum suaviorem prostate cancer per versican vulvam in cellula affectum. Res cancer MMIII: LXIII: 4786-91. View abstracto.
139. Rozenfeld V, Crain, s Callahan AK ert aequale. Fieri potest augmentum per modum warfarin glucosamine, chondroitin. Salutem J am syst pharm MMIV: LXI: 306-307. View abstracto.
140. De Caro A, Perola E, B Bartolini, et al. Velamine inhibere tres fractiones chemica oversulphated galactosaminoglycan Sulphates Virus; Virus genus humanum I, et I generis humani Herpesviridae; Herpesviridae; Virus. Res Antivir Chemother MCMXCIX: X: 33-8 .. View abstracto.
141. Danao, chondroitin et glucosamine Camara T. Potential parte effectus in curatio est. Rheum arthritis MM: XLIII: MMDCCCLIII. View abstracto.
142. Joel Cohen M, R Wolfe, Mai T, D. Ludovicum A randomized, duplex caecus, placebo sobrie iudicium continet de topici crepito glucosaminum sulfate, chondroitin sulfate et caphura, quia OSTEOARTHRITIS de genu. J Rheumatol MMIII: XXX: 523-8 .. View abstracto.
143. A Baici, Horler D, B natura probavit ABH, et al. Analysis de human serum post glycosaminoglycans in oralis administratione chondroitin sulfate. Int Rheumatol MCMXCII: XII: 81-8 .. View abstracto.
144. Richy F, Bruyère Domine, Domine Ethgen, et al. Chondroitin et glucosamine OSTEOARTHRITIS de genu in virtute continentibus quinque signa: a meta-analysis comprehensive. Interne arcus med MMIII: CLXIII, 1514-22. View abstracto.
145. Henrici de Aestimatio B. Launois, uti financial impulsum Chondrosulf CD in current medicinae usu. Ex parte enim scientificus tenuit in Symposio facile credebatur EULAR Symposium: accedit Nova OA: Chondroitin sulfate (VI & CS IV) Non solum autem symptomatic curatio. Clementine_Vulgate, MCMXCVIII.
146. Carwood G, S Goemaere, Veys EM. Systems sunt OSTEOARTHRITIS et perpendat et progressum in digito iuncturam morbo ex modifying OSTEOARTHRITIS ad effectus pharmaca. Clin Rheumatol MMII: XXI: 231-43. View abstracto.
147. Tallia ip- ftus AF, Cardone vivit. Chondroitin et glucosamine, asthma exacerbation consociata supplementum. Sum FAM J Board Pract MMII, XV, 481-4 .. View abstracto.
148. Ricciardelli C, D Quinn, WA Raymond, et al. Leuatus campester peritumoral chondroitin sulfate autem pauper est deploratae in predictive tractata ab aegris radicitus prostatectomy est diluculo-scaena prostate cancer. Res cancer MCMXCIX, LIX, 2324-8. View abstracto.
149. Ylisastigui L, N Bakri, Amzazi S, et al. RANTES actio anti-virales infectio per potentiate glycosaminoglycans non solutum est primaria per macrophages Herpesvirus hominis type 1. MM Virus; CCLXXVIII, 412-22. View abstracto.
150. A. Adebowale: DS Orff, Liang Z, et al. Glucosaminum et analysis of venalicium chondroitin sulfate contentus in-II permeability de Caco products et rudis materiae chondroitin sulfate. JANA MM, III, 37-44.
151. CAO LC, Boeve ER, wc de Bruijn, et al. Et Glycosaminoglycans semisynthetic sulfated polysaccharides: an overview of potential eorum applicationem in curatio de cum aegris urolithiasis. Urologia MCMXCVII, L, 173-83. View abstracto.
152. Cicero LM. Et curatio coronarius cor morbo et arteriosclerotic chondroitin sulfate-A: praevia fama. S. Ego sum Geriatr MCMLXVIII: XVI: 779-85. View abstracto.
153. Cicero aequales, Bajwa GS alfin Slater, RB, Ershoff BH. Vascularium laesiones ne per aortam arteriam coronariam chondroitin sulfate A a muribus adductam hypervitaminosis D cibum contineat turpis. ATHEROSCLEROSIS MCMLXXII: XVI: 105-18. View abstracto.
154. Mazieres B, B vulnera Combe, Phan Van A, et al. Chondroitin sulfate apud OSTEOARTHRITIS de genu: futurum est, duplex caecus, placebo multicenter orci studium regeret. J Rheumatol MMI: XXVIII: 173-81. View abstracto.
155. A De Jr Hammad TA. Glucosaminum simul efficacia FCHG49 dose, chondroitin TRH122 humilis sodium sulfate et hypothetica pondus genu manganese ascorbate administrationem imperfecta. MM Karthaginis imperfecta, VIII, 343-50. View abstracto.
156. Board cibum et nutritionem, Institute of Medicine. Reference puritate alimentorum essartis Vitaminum A, Vitaminum K, Pisces, Boron, Chromium, Cuprum, IODUM, ferrum, manganese, molybdenum, nickel, Silicon, vanadium, et Cadmiae. Washington, DC: National Museum Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
157. VR Pipitone. Chondroprotection cum chondroitin sulfate. Res Medicinae Exp Clin MCMXCI: XVII: 3-7. View abstracto.
158. Leffler CT Philippos ip- ftus AF, Leffler SG, et al. Glucosaminum, chondroitin et manganese Ascorbate ad iuncturam degenerative morbo, vel ex humilis retro genu: a randomized, duplex caecus, placebo-sobrie gubernatori studium. Mil Med MCMXCIX, CLXIV, 85-91. View abstracto.
159. Silvestri L. Lanzarotti E, E Marchi, et al. Deuterium Farmacocinética Humanum Domini, per glycosaminoglycans intitulatum distenta et substantias pro oris quod effusio. Semin Thromb Hemost MCMXCIV: XX: 281-92. View abstracto.
160. Conte A, N Volpi: rectangulum ^ L, et al. Et facies diam pharmacokinetic oris curatio cum chondroitin sulfate. MCMXCV Arzneimittelforschung: XLV: 918-25. View abstracto.
161. Ronca F, E Palmieri, Panicucci P, et al. Actus odii inflammatione chondroitin sulfate. Osteogenesis imperfecta Karthaginis MCMXCVIII, Suppl A VI: 14-21. View abstracto.
162. Andermann G Dietz itinere administrationis ad M. influentia alicuius Bioavailability endogena macromolecule: chondroitin sulphate (CSA). J medicamentis Metab Pharmacokinet MCMLXXXII: VII: 11-6. View abstracto.
163. A Conte, de Bernardi M, rectangulum ^ L, et al. Metabolicae fata virum in exogenous chondroitin sulfate. Arzneimittelforschung MCMXCI, XLI, 768-72. View abstracto.
164. McAlindon TE, LaValley praeservatusm, Gulin JP, Felson DT. Chondroitin et glucosamine, quia curatio OSTEOARTHRITIS: a meta-taxationem et qualis systematica analysis. JAMA MM, CCLXXXIII, 1469-75. View abstracto.
165. Limberg MB, McCaa C, Kissling GE, HE Kaufman. General applicationem ex hyaluronic acidum et chondroitin sulfate in curatio de siccis oculis. J am Ophthalmol MCMLXXXVII, CIII, 194-7. View abstracto.
166. Song peccato Adami implicantur. In partes chondroitin et glucosamine sulfate sulfates ad iuncturam degenerative morbo curatio. Altern med MCMXCVIII, Apoc: III: 27-39. View abstracto.
167. Bucsi Dominum, Pauper et tolerability et G. operationes efficaciam oris chondroitin sulfate quasi signa tardus agendi medicamento, quia OSTEOARTHRITIS (SYSADOA) in curatio OSTEOARTHRITIS de genu. Osteogenesis imperfecta Karthaginis MCMXCVIII, Suppl A VI: 31-6. View abstracto.
168. Medii ordinis civium P: Chales G, J Dehais, et al. Efficaciam autem et tolerability chondroitin sulfate MCC mg / die III vs chondroitin sulfate x CD mg / die nobis placebo. Osteogenesis imperfecta Karthaginis MCMXCVIII, VI, 25-30. View abstracto.
169. Uebelhart D, Thonar EJ, Delmas PD, et al. OSTEOARTHRITIS de genu super progressum effectus ab oris chondroitin sulfate, et gubernatori studium. Osteogenesis imperfecta Karthaginis MCMXCVIII, VI, 39-46. View abstracto.
170. Cicero M, N. Enrick Infarctus; reductionem rate of mortem ab A. chondroitin sulfate Angiológia MCMLXXIII: XXIV: 269-87. View abstracto.
171. Jean-CI. Publicam et salutem de quadam littera ipsa impraesentiarum repetere et vestibulum firms aut importatur quae propria puritate alimentorum supplemento, quod bubula texturis.FDA. Available at: www.cfsan.fda.gov/~dms/dspltr05.html.
172. Leeb BF quandam addidimus, Schweitzer H, K Donnerstag, Smolen Victoria. A analysis of meta-chondroitin sulfate in treatment of OSTEOARTHRITIS. J Rheumatol MM: XXVII: 205-11. View abstracto.
173. Bagasra O, P, Nicolas, Heins B, Pomerantz Marcus Tullius. Anti-virus hominis type I est operatio sulfated monosaccharides, polysaccharides et alia collatio cum sulfated polyions. J Infect Dis MCMXCI, CLXIV, 1082-90. View abstracto.
174. Jurkiewicz E, P panse, Jentsch tangentibus KD, et al. Herpesvirus hominis actio anti-VIDH-I de polysulphate chondroitin. Donec MCMLXXXIX, III, 423-7. View abstracto.
175. Chavez ML. Chondroitin et glucosamine sulfates sulfate. Virus pharm MCMXCVII: XXXII: 1275-85.
176. Mazieres B, G Loyau, Menkes CI, et al. [Chondroitin sulfate in curatio de gonarthrosis et coxarthrosis. -Sobrie duplex caecus multicenter consequuntur menses V de futurum usus studio placebo]. Psalm Rhum Mai Osteoartic MCMXCII, LIX, 466-72. View abstracto.
177. Conrozier T. [anti-Arthrosis treatments: sulfates chondroitin eidem virtus, de tolerantia]. Presse Med MCMXCVIII: XXVII: 1862-5. View abstracto.
178. Morreale P: Manopulo R, M Galati; et al. Collatio de anti-inflammatory effectum in chondroitin sulfate sodium et diclofenac cum aegris genu OSTEOARTHRITIS. J Rheumatol MCMXCVI, XXIII, 1385-91. View abstracto.

From Review - 02/20/2020